Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model

Documenti analoghi

• New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE
  di: Qianhui Fu, et al.
  Pubblicazione: (2024)
• Identification of mitophagy‐related biomarkers in osteoarthritis
  di: Shiqiang Ruan, et al.
  Pubblicazione: (2024)
• An in vivo assay for osteoclast activity using mouse calvaria
  di: Christopher Grieg, et al.
  Pubblicazione: (2025)
• Exploring the co‐morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model
  di: Mingfeng Li, et al.
  Pubblicazione: (2025)
• Development, validation, and preliminary phenotypic characterization of a Col6a3 knockout mouse model targeting exon 3
  di: Michel ElChoueiry, et al.
  Pubblicazione: (2025)